UK prescribing should follow SmPC and NICE guidance
Tirzepatide dosing is not one-size-fits-all, and clinics that treat it that way are doing their patients a disservice
When you take semaglutide, it activates certain receptors in your body that respond to GLP-1, leading to increased insulin production, reduced sugar release from the liver, and suppressed appetite
Frontiers in Psychology, 13, 907637
Retatrutide dosing in trials follows a step-up approach, with increases every 4 weeks, similar to GLP-1 medications, to help your body adjust to side effects
Consultation with a healthcare provider is crucial to determine the appropriate dosing schedule and ensure safe and effective use of these medications